The interpretation of this as a move towards doing the Phase 3 in-house is straight forward but I agree it can also be viewed the other way. Neuren is a pretty small company and there probably exists a very high level of camaraderie amongst the staff. Some are likely great friends. In the event of a takeover, those not amongst upper management with large stock holdings would basically just lose their job. So this may provide a mechanism for making such an event far less onerous. Now if I was involved in the takeover offer I would certainly be putting forward arguments to minimise the cost of this but it would be a point of debate and the basic point stands.
- Forums
- ASX - By Stock
- NEU
- Ann: Notification regarding unquoted securities - NEU
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.96%
!
$13.23

Ann: Notification regarding unquoted securities - NEU, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.23 |
Change
0.380(2.96%) |
Mkt cap ! $1.626B |
Open | High | Low | Value | Volume |
$13.15 | $13.34 | $12.92 | $3.683M | 281.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 359 | $13.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.23 | 158 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 147 | 13.260 |
6 | 255 | 13.250 |
10 | 687 | 13.240 |
5 | 611 | 13.230 |
7 | 1529 | 13.220 |
Price($) | Vol. | No. |
---|---|---|
13.280 | 339 | 8 |
13.290 | 334 | 2 |
13.300 | 444 | 3 |
13.310 | 615 | 4 |
13.320 | 1202 | 4 |
Last trade - 11.40am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online